je.st
news
Synta Pharmaceuticals Closes Public Offering of Common Stock
2013-11-19 12:52:57| Biotech - Topix.net
Gross proceeds to Synta are approximately $60.4 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Synta.
Tags: public
stock
common
offering
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||